Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...

For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says. Scientists at Duke ...

Walmart will offer in‑store pickup of Eli Lilly’s discounted weight‑loss drug Zepbound, giving self‑pay customers easier, ...

Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s ...

Duke University scientists have discovered that pancreatic alpha cells, long believed to only produce glucagon, actually generate powerful amounts of GLP-1 — the same hormone mimicked by popular ...

An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used ...

Without proper management, insulin resistance could develop into type 2 diabetes and increase your risk of stroke, cancer, and weight gain.

IQ+, our most advanced algorithm ever, together with the benefits of Abbott's latest CGM sensor on our tested and trusted ...

The state's top officials just announced a landmark initiative to slash insulin prices, beginning on this date.

The specialty grocer, which spends millions each year on insulin for employees, accused the companies of profiting from ...